Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VIO-01 by Valerio Therapeutics for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
VIO-01 is under clinical development by Valerio Therapeutics and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to...
VIO-01 by Valerio Therapeutics for Metastatic Ovarian Cancer: Likelihood of Approval
VIO-01 is under clinical development by Valerio Therapeutics and currently in Phase II for Metastatic Ovarian Cancer. According to GlobalData,...
VIO-01 by Valerio Therapeutics for Metastatic Prostate Cancer: Likelihood of Approval
VIO-01 is under clinical development by Valerio Therapeutics and currently in Phase II for Metastatic Prostate Cancer. According to GlobalData,...
VIO-01 by Valerio Therapeutics for Metastatic Breast Cancer: Likelihood of Approval
VIO-01 is under clinical development by Valerio Therapeutics and currently in Phase II for Metastatic Breast Cancer. According to GlobalData,...
VIO-01 by Valerio Therapeutics for Solid Tumor: Likelihood of Approval
VIO-01 is under clinical development by Valerio Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...